Inactive Instrument

News Sinopharm Group Co., Ltd. Other OTC

Equities

SHTDY

US82937K1016

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

China Grants Registration Approval for Shanghai Shyndec Pharmaceutical Unit's Flu Injection	05-15	MT
China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status	05-14	MT
Wall Street Cues, Property Outlooks Lift Asian Stock Markets	04-29	MT
China, Hong Kong stocks rise, led by property shares	04-29	RE
Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Sinopharm Group Shares Fall as Higher Costs Cut Into Quarterly Profit	04-28	DJ
Sinopharm Group's Q1 Profit Falls as Operating Costs Rise	04-28	MT
Central Bank, Tech Outlooks Lift Major Asian Stock Markets	04-26	MT
Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets	04-16	MT
Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials	04-10	MT
China Production Bases of Shyndec Pharmaceutical's Unit Gets Compliance Certification from Australian Regulator	03-27	MT
Sinopharm's Attributable Profit Jumps in 2023 on Higher Revenue	03-24	MT
Sinopharm Group Co. Ltd. Proposes Final Dividend of for the Financial Year Ended 31 December 2023, Payable on 13 August 2024	03-24	CI
Sinopharm Group Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-24	CI
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	03-21	MT
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	03-21	MT
US Inflation, Light News Flow Churns Asian Stock Markets	03-13	MT
Sinopharm Group Co. Ltd. Announces Change of Registered Address	03-12	CI
Nomura Adjusts Sinopharm Group’s Price Target to HK$32.39 Form HK$33.31, Keeps at Buy	03-11	MT
China Traditional Chinese Medicine's Stock Bolts on Privatization Offer	02-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sinopharm Group Co., Ltd. Other OTC

Equities

SHTDY

US82937K1016

Summary

Filters